LINC00173 and lung carcinoma: To determine the primary isoform of LINC00173 in lung cancer, we further analyzed the RSEM percentages of LINC00173.v1 and LINC00173.v2 based on their reads in the lung cancer dataset from TCGA, and found that the RSEM percentage of LINC00173.v1 was higher than that of LINC00173.v2 in ANT (91.8%), ADC (91.9%) and SQC (94.2%) (Fig. 1g).